Portfolio Valuation: Life Sciences Investments
Pension Plan Needs Life Sciences Investment Portfolio Valuation
Fairness Opinion: Distressed M&A
Private Company Under Financial Distress Considering Transaction Alternatives
Inventory and Assessment: Healthcare System’s Oncology Data Assets
Comprehensive Inventory & Assessment of Integrated Health System’s Oncology Data
Jake Frank, SmithRx
“I love the RNA team. They get healthcare and we’ve worked with the team both in valuation advisory capacities as well as on strategic projects for us as we take SmithRx to the next level. These guys get it!”
Buy-Side Due Diligence: Organ on a Chip
Buy-side Due Diligence Support for a Potential Investor
